Identification of two genes associated with recurrence in Paget’s disease and construction of a predictive model
RNA-seq (gene expression) · human · 39 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 39 samples: 28 × MPD vs 11 × EMPDGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE328302_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1454522. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 39 samples.
How we read this: 2 replicated groups read from 39 sample titles; they account for 39 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9678239 EMPD1 EMPD
- GSM9678240 EMPD2 EMPD
- GSM9678241 EMPD3 EMPD
- GSM9678242 EMPD4 EMPD
- GSM9678243 EMPD5 EMPD
- GSM9678244 EMPD6 EMPD
- GSM9678245 EMPD7 EMPD
- GSM9678246 EMPD8 EMPD
- GSM9678247 EMPD9 EMPD
- GSM9678248 EMPD10 EMPD
- GSM9678249 EMPD11 EMPD
- GSM9678250 MPD1 MPD
- GSM9678251 MPD2 MPD
- GSM9678252 MPD3 MPD
- GSM9678253 MPD4 MPD
- GSM9678254 MPD5 MPD
- GSM9678255 MPD6 MPD
- GSM9678256 MPD7 MPD
- GSM9678257 MPD8 MPD
- GSM9678258 MPD9 MPD
- GSM9678259 MPD10 MPD
- GSM9678260 MPD11 MPD
- GSM9678261 MPD12 MPD
- GSM9678262 MPD13 MPD
- GSM9678263 MPD14 MPD
- GSM9678264 MPD15 MPD
- GSM9678265 MPD16 MPD
- GSM9678266 MPD17 MPD
- GSM9678267 MPD18 MPD
- GSM9678268 MPD19 MPD
- GSM9678269 MPD20 MPD
- GSM9678270 MPD21 MPD
- GSM9678271 MPD22 MPD
- GSM9678272 MPD23 MPD
- GSM9678273 MPD24 MPD
- GSM9678274 MPD25 MPD
- GSM9678275 MPD26 MPD
- GSM9678276 MPD27 MPD
- GSM9678277 MPD28 MPD
- GSE316750 Individualized transcriptomic changes in malignant and benign prostate identify markers of disease recurrence 82 samples shares recurrence
- GSE264196 A 50-gene high-risk profile predictive of COVID-19 and Idiopathic Pulmonary Fibrosis mortality originates from a molecular imbalance in monocyte and T-cell subsets that reverses in survivors with post-COVID-19 Interstitial Lung Disease 20 samples shares predictive
- GSE278695 Screening and Modeling of LUAD-Associated Predictive and Prognostic Genes Based on Multi-Omics Data 50 samples shares predictive
- GSE100833 A functional genomics predictive network model identifies regulators of inflammatory bowel disease: Microarray Analysis of Human Blood and Intestinal Biopsy Samples from a Phase 2b, Double-blind, Placebo-controlled Study of Ustekinumab in Crohn's Disease 1717 samples shares predictive
- GSE271689 Enhancing Immunotherapy Outcomes: Spatial Multi-Omics Predictive Models for Non-Small Cell Lung Cancer 586 samples shares predictive
- GSE245484 Predictive prioritization of enhancers associated with pancreatic disease risk 66 samples shares predictive
- GSE255359 High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for anti-fibrotic therapy in HER2-negative breast cancer 108 samples shares predictive
- GSE254942 The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma 106 samples shares predictive
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.